Want to create interactive content? It’s easy in Genially!

Get started free

THIS IS WHAT WE GONNA USE :)

Lily Ward

Created on November 5, 2025

Start designing with a free template

Discover more than 1500 professional designs like these:

Timeline video

Images Timeline Mobile

Sport Vibrant Timeline

Decades Infographic

Comparative Timeline

Square Timeline Diagram

Timeline Diagram

Transcript

1900s - Morphine Addiction

A Historical Perspective of Narcotics Substance Abuse

1914 - The Harrison Narcotics Tax Act

1930s - The Rise of Black Market Narcotics

1906 + 1907 - Heroin

1917 - World War I

1940s - World War II

1990s - Oxycontin Opioid Crisis

1970s - Controlled Substances Act

1950s - Heroin Abuse

Background

1980s - Heroin, HIV/AIDS, and War on Drugs

1960s - Methadone Introduction

Key Points

2004 - "Pill Mill" Crisis

Lessons Learned

2010 FETANYL ERA... INTRODUCE?

Future Implications

2000s - Percocet and Vicodin Crisis

2003 - Hydrocodone and Oxycodone Abuse

2009 - Second Wave of Opioid Crisis

2022 X-waiver

2025 Halt movement

2015 - FDA Approved Narcan

2020 Covid-19 Pandemic

2024 Decline

Fentanly Era

In the early 2010s, the United States entered the “fentanyl era,” when illicitly manufactured fentanyl began to rapidly drive overdose deaths. Starting around 2013, death rates involving synthetic opioids other than methadone, mainly fentanyl, rose sharply and by 2020 these drugs were involved in nearly three quarters of all opioid‑involved overdose deaths. Fentanyl was increasingly mixed into heroin, counterfeit pills, methamphetamine, and cocaine, which meant many people overdosed without knowing their drugs contained fentanyl. Public health responses during this period focused on expanding naloxone access, increasing availability of medications for opioid use disorder, and improving monitoring of the drug supply

2000s - Percocet and Vicodin Crisis
  • In the early 2000s, prescriptions for painkillers like Percocet and Vicodin rose sharply, often driven by a growing emphasis on aggressive pain treatment.
  • These medications were widely seen as safe, leading many people to underestimate their addictive potential.
  • Misuse and overprescribing contributed to rising addiction rates, setting the stage for a broader nationwide opioid crisis.
  • Communities and healthcare systems began noticing increases in dependence, overdoses, and doctor-shopping, prompting calls for better prescribing guidelines and patient education.

1950s - Heroin Abuse

  • In the 1950s, heroin abuse began drawing growing public attention in the United States, especially in big cities where post-war social changes left some communities struggling with limited resources and rising stress. Young people were increasingly exposed to the drug, and addiction often carried heavy stigma and few treatment options. Public health officials and community leaders started recognizing heroin use as a serious medical and social issue, setting the stage for later efforts to develop better support and treatment approaches.

1980s - Heroin, HIV/AIDS, and War on Drugs

  • The "War on Drugs" intensified under President Reagan, emphasizing criminalization rather than treatment.
  • Heroin use spread rapidly in urban area, and needle sharing contributed significantly to the HIV/AIDS epidemic.
  • Policies imposed mandatory minimum sentencing and disproportionately affected Black and Latino communitites.
  • Public fear of drug-related crime and disease shaped punitive approaches rather than healthcare-based interventions.
X-Waiver

In December 2022, the Mainstreaming Addiction Treatment (MAT) Act eliminated the federal X-waiver requirement that previously restricted which doctors could prescribe buprenorphine for opioid use disorder. This historic change allows any DEA-registered practitioner licensed to prescribe controlled substances to treat patients with addiction, removing barriers that left many communities without access to life-saving medication. Before the MAT Act, only 5% of U.S. physicians were X-waivered to prescribe buprenorphine, creating severe treatment gaps especially in rural and underserved areas. The elimination of this requirement integrates addiction treatment into mainstream medicine and reduces stigma by treating substance use disorder like any other chronic condition

Future Implications:

  • The long-term public health crisis of narcotic substance abuse will require ongoing attention to changing harm-reduction strategies, treatment models, and drug laws.
  • There will be long-term effects on healthcare systems, such as a rise in the need for integrated medical-behavioral therapy, greater availability of medication-assisted therapies, and improved provider education.
  • The importance of education and prevention initiatives will only increase, with an emphasis on community-based outreach, early intervention, and stigma reduction.
  • Future outcomes at the social and community level include the requirement for more extensive support systems, better access to mental health care, and laws that deal with the social factors that influence substance use.
HALT Fentanyl Act
July 16, 2025 - Signed into law

In July 2025, the HALT Fentanyl Act was signed into law, making the temporary emergency scheduling of all fentanyl-related substances permanent as Schedule I drugs. This legislation closed a loophole that allowed drug traffickers to alter fentanyl’s chemical structure to create new, previously unscheduled “copycat” drugs.

The law imposes strict penalties for manufacturing, possessing, or trafficking these substances, aiming to curb the devastating impact of synthetic opioids, which were responsible for over 68% of U.S. overdose deaths in 2022 Fentanyl and its analogues caused over 74,000 U.S. overdose deaths in 2022

Harm Reduction/Narcan
  • Harm reduction programs are public health services that lower the harms of drug use, such as overdose and infection, without requiring a person to stop using drugs. Common harm reduction services include naloxone distribution, syringe service programs, safer use supplies, and connections to medications for opioid use disorder and other health care. These programs are linked with fewer fatal overdoses and lower rates of HIV and hepatitis C among people who inject drugs, and with greater use of health and treatment services
  • Naloxone was first approved by the FDA in 1971 as an injectable medicine to reverse opioid intoxication and overdose. NARCAN nasal spray, an intranasal form of naloxone, was then approved by the FDA in 2015 as a prescription product for emergency treatment of suspected opioid overdose. In March 2023, the FDA approved NARCAN 4 mg nasal spray as the first naloxone product for over‑the‑counter, nonprescription use in the United States.

Lessons Learned:

  • Substance use has been a part of human history for centuries: early civilizations used drugs and alcohol for medicine, spiritual rituals, and social gatherings.
  • Cultural attitudes influence how people use drugs: some societies accept substances like alcohol or tobacco, while others condemn them.
  • The 20th century “War on Drugs”: emphasized criminalization over treatment, disproportionately affecting marginalized communities.
  • Medical understanding evolved: addiction was viewed as a disease rather than a choice, leading to modern treatment approaches.
  • Social stigma continues to impact recovery: this shows how historical attitudes still influence public perception today.
  • Public health approaches have proven to be more effective than disciplinary measures in addressing addiction long-term.
  • In 2004, concerns about opioid misuse grew as “pill mill” clinics spread in areas like Florida and Appalachia, where some doctors and clinics were prescribing pain medications with little medical oversight. As a result, emergency rooms saw a noticeable rise in visits related to misuse, overdoses, and complications from high-dose pain medications. This period marked a clear warning sign that prescription opioid misuse was becoming a much larger public health issue.
  • A “pill mill” is a clinic, doctor’s office, or pain management center that prescribes large amounts of controlled substances with little or no medical justification.
  • Patients can get opioid prescriptions quickly and easily, often after minimal or no physical exam.
  • Clinics may accept cash only, which avoids insurance oversight.
  • Large crowds or long lines of people waiting for prescriptions are common.
  • Prescribing patterns are unusually high compared to legitimate medical practices.

2004 - "Pill Mill" Crisis

1900s

In this century, morphine was commonly used for severe pain, and became popular for use during the civil war. It was a heavily prescribed narcotic during this time, and used for a wide range of medical issues. In addition, the fact that it was widely prescribed to many led to heavy addiction to the drug.https://www.narconon.org/drug-information/heroin-history-1900s.html

1914 Harrison Narcotics Tax Act

It was the first major federal laws to control opiods and cocaine to regulate, instead of banning. This law required anyone who imported, produced, sold or whoever give narcotics to register, pay taxes and required to have records of transactions. This restricts to people who could legally access these drugs because morphine and cocaine were widely available in patent medicines and clinical settings. In the long run, this law helped to lay the groundwork for drug-control policy, to shape the approach of the US in pain management and substance use disorder.

Covid-19 pandemic

  • In 2020, the Centers for Disease Control and Prevention reported 91,799 overdose deaths in the United States, which was about a 30 percent increase from 2019 and the highest number ever recorded in a single year. During the COVID‑19 pandemic, federal agencies allowed rapid changes such as letting buprenorphine treatment be started and managed through telehealth, including video visits and phone calls, and letting more patients take methadone doses home instead of visiting clinics daily. At the same time, many adults and young people reported using substances like alcohol and marijuana more often to cope with stress, anxiety, boredom, and social isolation related to the pandemic and lockdowns
March 2022

WHO releases data showing that the COVID-19 pandemic triggered a 25% increase in anxiety and depression worldwide, with young people and women at the highest risk. The number of recorded deaths due to COVID-19 reaches 976,229, with more than 79,853,683 total reported cases of the virus in the U.S.

1906 + 1907

In 1906, heroin was approved by the American Medical Association (AMA). In addition, the Pure Food & Drug Act of 1906 was passed due to heroin being a hidden ingredient in cough syrups. This law required an accurate label of ingredients in the medication. This impacts the consumers unknowingly using products containing heroin. 1907: It became a growing medical and public concern due to of the misuse of the narcotic, and the overall common use of cough medicine.

Key Points:

  • Ancient civilizations used alcohol, cannabis, and opium for rituals, medicine, and recreation
  • The invention of morphine (1804), hypodermic needles (1853), and thereafter heroin, resulted in a widespread addiction problem, particularly after wars such as the U.S. Civil War.
  • The Harrison Narcotic Act (1914) marked the beginning of the Federal regulation of all addictive drugs in the U.S
  • Alcoholics Anonymous (AA) was founded in 1935, which shifted the recovery process towards group therapy and peer support.
  • Government responses include, Comprehensive Alcohol Abuse and Alcoholism Prevention, Treatment and Rehabilitation Act (1970) National Institute on Drug Abuse (1974), which increased research, funding, and services for treatment and prevention.
  • Medication-Assisted Treatment (MAT) began with methadone in the 1960s and continued with the FDA approval of naltrexone (1994) and buprenorphine (2002), providing patients with more effective options for opioid addiction.
  • Naloxone was approved by the FDA in 1971 for the reversal of opioid overdoses, and was approved later in 2015 for use as a nasal spray and in 2023 became available over the counter
  • Since the 1990s, Naloxone distribution and syringe service programs have become well-known for harm reduction strategies that reduce overdose deaths and infectious diseases.

Overdose Death Decrease

In 2024, for the first time in years, fewer people died from drug overdoses in the United States. Deaths fell by about one quarter, from roughly 108,000 in 2023 to around 80,000 in 2024, meaning approximately 27,000 people who might have died instead survived. Fentanyl and other synthetic opioids are still the main cause of overdose deaths, but the total number dropped because more people had access to help when they needed it. This decline happened after communities expanded naloxone distribution, removed barriers so more doctors could prescribe medications for opioid use disorder, and offered more harm reduction services like syringe programs and outreach.

2003 - Hydrocodone and Oxycodone Abuse

  • Hydrocodone and oxycodone misuse moves into the spotlight:
By 2003, state health departments were increasingly alarmed by sharp rises in emergency room visits, addiction reports, and overdose cases linked to medications like Vicodin (hydrocodone) and OxyContin/Percocet (oxycodone). These drugs, once seen as routine tools for pain management, were now recognized as major contributors to a growing wave of prescription drug misuse.
  • Growing recognition of “doctor-shopping” and overprescribing:
Health officials noticed concerning prescription behaviors: patients visiting multiple physicians to obtain more pills, pharmacies filling unusually high volumes, and certain clinics prescribing disproportionately large amounts. This triggered widespread discussions about the need for more regulated tracking of controlled substances.
  • First wave of Prescription Drug Monitoring Programs (PDMPs):
In response, several states initiated the development or modernization of PDMPs: electronic databases designed to track prescriptions for controlled substances. These early systems allowed pharmacists and healthcare providers to check whether a patient was already receiving opioids elsewhere. Although the technology was still early-stage and not yet standardized nationally, PDMPs represented one of the first coordinated policy efforts to curb opioid misuse.
March 2022

WHO releases data showing that the COVID-19 pandemic triggered a 25% increase in anxiety and depression worldwide, with young people and women at the highest risk. The number of recorded deaths due to COVID-19 reaches 976,229, with more than 79,853,683 total reported cases of the virus in the U.S.

1917 - World War I

  • The U.S enters World War I, increasing the medical use of morphine and other opioids to treat battlefield injuries.
  • Thousands of injured soldiers developed morphine dependence, often referred to as "soldier's disease."
  • Wartime stress and trauma contributed to higher raters of sedative and opioid use among veterans.
  • The war highlighted the growing need for federal regulatiion of narcotics, which later influenced stricter laws.

WHO releases data showing that the COVID-19 pandemic triggered a 25% increase in anxiety and depression worldwide, with young people and women at the highest risk. The number of recorded deaths due to COVID-19 reaches 976,229, with more than 79,853,683 total reported cases of the virus in the U.S.

Lorem ipsum dolor

Consectetur adipiscing elit

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod.

  • Lorem ipsum dolor sit amet.
  • Consectetur adipiscing elit.
  • Sed do eiusmod tempor incididunt ut.

Lorem ipsum dolor sit

2009 - Second Wave of Opioid Crisis
  • By 2009, a troubling trend was emerging: many people who had become dependent on prescription opioids, like OxyContin or Vicodin, started turning to heroin. Heroin was often cheaper and easier to find than prescription pills, making it a more accessible option for those struggling with addiction. Public health officials began calling this shift the “second wave” of the opioid crisis, recognizing that the problem was evolving from prescription drug misuse into a larger issue involving illicit opioids. This period marked a critical turning point, highlighting the need for broader addiction treatment and prevention strategies.
1970s - Key Events in U.S Drug Policy
  • The CSA (Controlled Substance Act) consolidated all federal drug laws into one system and gave the government power to regulate manufacturing, distribution, and prescribing.
  • This law marked the start of strict federal drug control, setting the foundation for later U.S drug enforcement policies.
  • The act classified drugs like Heroin, LSD, and Cannabis as Schedule I, meaning "high abuse potential and no accepted medical use.
  • Laid the groundwork for the War on Drugs, which would be formally declared by President Nixon the following year (1971).

Background:

  • Substance abuse has been a longstanding and evolving issue in our American society. In the 19th century, unregulated opium, morphine, and cocaine led to dependence. Narcotic abuse dates back to ancient medicinal and ceremonial use of opium, later becoming recreational in the 18th and 19th centuries. As production and prescribing grew, dependence and health crises worsened, fueling the current opioid epidemic.
1930s - The Rise of Black Market Narcotics
  • After the Harrison Narcotics Act (1914) and the Prohibition Era, the 1930s saw a black market surge for narcotics such as heroin, morphine, and cocaine.
  • The 1937 Marijuana Tax Act criminalized cannabis nationally, marking the start of federal control and stigmatization of marijuana users.
  • Organized crime groups began profiting from illegal drug and alcohol markets during and after the Prohibition Era.

1990s -OxyContin and the Prescription Opioid Crisis

  • In 1996, oxycontin was introduced by Purdue Pharma, marketed as a safe pain management option with "low addiction risk."
  • Aggressive marketing compaigns led to widespread overprescription and dependence, igniting the prescription opioid crisis.
  • By the late 1990s, opiod addiction had shifted from street drugs to legally prescribed painkillers, setting the stage for the 2000s heroin and fentanyl epidemic.
  • Harm reducion and Medication- Assisted Treatment efforts began expanding in response to rising overdose deaths.
1940s - World War II and Substance Use
  • During World War II, stimulants like amphetamines were distributed widely among soldiers to maintain alertness and stamina in combat.
  • Returning veterans often faced addiction or dependency, contributing to early recognition of post-war drug misuse.
  • Wartime stress, pain management, and medical advances led to expanded use of opiods and sedatives in both military and civilian populations.

1960s - Methadone Introduced

  • Methadone has an interesting history that starts in the 1930s and 40s, when German scientists were searching for a new pain reliever. After World War II, the medication made its way to the United States, where researchers discovered its unique long-acting effects. By the 1960s, methadone became an important treatment option for people with opioid dependence, helping reduce withdrawal symptoms and support recovery. Today, it remains a well-studied and widely used medication, valued for its stability and reliability in medical care.